On September 1, bio.logis digital health GmbH received the “E-Health Award Hessen 2021” for its digital pharmacogenetic application “GIMS.pharma” in the category “Example of care with high patient benefit” at the E-health Congress in Frankfurt am Main. With this award, the Hessian Ministry for Social Affairs and Integration promotes exemplary digitization projects in the public healthcare.
On behalf of the organizing committee, we are delighted to welcome you at the 7th U-PGx Personalized Medicine Day that will be organized in Ljubljana, Slovenia on March 24th, 2021.
The meeting will be co-organized by the Golden Helix Foundation and the University of Ljubljana, both partners of the Ubiquitous Pharmacogenomics (U-PGx) project, funded by the European Commission (H2020-668353). This international event is open for clinical pharmacologists, hospital pharmacists, general pharmacists, specialists, general practitioners, medical students, laboratory technicians, regulators, healthcare insurers and others interested in pharmacogenomics.
In light of the coronavirus pandemic, the U-PGx Executive Board has made the decision to hold the 7th U-PGx Personalized Medicine Day as a VIRTUAL meeting and the meeting will start at 9 am CET.
We look forward to a successful meeting.
September 29th, 2020 was a memorable day as Cristina Lucía Dávila Fajardo obtained her (second!) PhD degree from Leiden University in the Netherlands. Since 2010, she collaborates with Prof. Henk-Jan Guchelaar and Dr. Jesse Swen from the Leiden University Medical Center in pharmacogenetics research.
On September 2nd, 2020 Cathelijne van der Wouden obtained her PhD degree from Leiden University in the Netherlands. She started her PhD in 2016 in the research group of Prof. Henk-Jan Guchelaar and Dr. Jesse Swen from the Leiden University Medical Center.
The 3rd U-PGx Personalized Medicine Public Day was successfully co-organized in Patras, Greece by the Golden Helix Foundation together with the University of Patras, Department of Pharmacy, Laboratory of Pharmacogenomics and Individualized Therapy (Patras, Greece). Continue reading
A practice paper “Educating the Next Generation of Pharmacogenomics Experts: Global Educational Needs and Concepts” analysing educational needs to develop pharmacogemomics from science to patient care and about our U-PGx perspective was recently published in Clinical Pharmacology & Therapeutics. Continue reading
One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use. Continue reading
In the PREPARE study participants are genotyped pre-emptively, but what to do for all other patients? Can you initiate therapy without pre-emptive testing or is genotyping necessary for specific drugs? Continue reading